Heterogeneity of the cytokinome in undifferentiated arthritis progressing to rheumatoid arthritis and its change in the course of therapy. Move toward personalized medicine
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- The role of cytokines in the pathogenesis of rheumatoid arthritis – Practical and potential application of cytokines as biomarkers and targets of personalized therapyCytokine, 2015
- The role of the Th17 cytokines IL-17 and IL-22 in Rheumatoid Arthritis pathogenesis and developments in cytokine immunotherapyCytokine, 2015
- How undifferentiated arthritis evolves into chronic arthritisBest Practice & Research Clinical Rheumatology, 2014
- Clinical Biomarkers and Pathogenic-Related Cytokines in Rheumatoid ArthritisJournal of Immunology Research, 2014
- When and where does inflammation begin in rheumatoid arthritis?Current Opinion in Rheumatology, 2014
- Changes in Proliferation Kinetics of T Cells: A New Predictive Cellular Biomarkers for Early Rheumatoid Arthritis?Journal of Clinical Immunology, 2012
- A Cytokine-Centric View of the Pathogenesis and Treatment of Autoimmune ArthritisJournal of Interferon & Cytokine Research, 2011
- The number of elevated cytokines and chemokines in preclinical seropositive rheumatoid arthritis predicts time to diagnosis in an age‐dependent mannerArthritis & Rheumatism, 2010
- The need for prognosticators in rheumatoid arthritis. Biological and clinical markers: where are we now?Arthritis Research & Therapy, 2008
- EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)Annals of the Rheumatic Diseases, 2007